Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2013

Apr 3, 2013

30291_dirs_2013-04-03_9d6827ec-b800-473a-a431-437484865bc1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2013-04-01

Reporting Person: SCANGOS GEORGE A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-04-01 Common Stock S 1598 $193.66 Disposed 52107 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5378 Indirect
Common Stock 5378 Indirect

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2: This amendment is being filed solely to file the power of attorney as an exhibit. No changes have been made to the transactions reported by the reporting person in his Form 4 filed with the SEC on April 2, 2013.